Scientific News
Pneumonia involves shifts in the entire lung microbial community, which interact with a person’s immune response.
Maurizio Vecchi, gastroenterologist at Policlinico of Milan (Italy), discussed the current and potential role of the microbiome in inflammatory bowel disease (IBD).
Supporting maternal gut health and optimizing breast milk composition could help shape healthy infant gut development.
Mechanisms involve medium-chain fatty acids, inflammatory activation of macrophages, reduced vagal signalling, and lower hippocampal activation.
Gianfranco Grompone, Chief Scientific Officer at BioGaia GA, discusses the new evidences about oral microbiome.
The findings may inform strategies to improve early-life gut health as well as infant nutrition and disease prevention.
Researchers identified 36 bacterial species, particularly Hungatella hathewayi and Intestinimonas butyriciproducens, associated with colorectal cancer.
When we eat, we are not adding energy to a furnace. We are running a programme. And like any programme, the outcome depends entirely on the operating system that interprets…
Pregnancy: how dysbiosis may affect placentation, maternal immunity, and the risk of neonatal sepsis
Maria Rescigno (Humanitas University, Rozzano, Milan) discusses the role of dysbiosis during pregnancy and the perinatal period, outlining two potential clinical trajectories.
Dietary protein influences V. cholerae growth, metabolism, virulence, and competition with gut microbes.
Some bacteria common in dog owners, particularly Streptococcus strains, were linked to fewer behavioral and attention problems.
Francesco Franceschi from Policlinico Universitario A. Gemelli IRCCS (Roma) focuses on bacterial translocation across a compromised intestinal barrier as a plausible pathway contributing to sepsis.
Lantibiotic-producing gut bacteria can prolong gut imbalance and increase susceptibility to dangerous infections after antibiotics.
MTB and aerolysin drive gut inflammation in ulcerative colitis.
William Fusco, gastroenterologist at Policlinico Universitario Agostino Gemelli, highlighted a recently published pilot study on post-infectious irritable bowel syndrome (IBS) framed within microbial precision medicine and biomarker-driven care.
Nutrient competition provides a predictive framework to anticipate and potentially mitigate drug side effects on the gut microbiota.
The interaction between gut microbes, the amino acid leucine and sIL-6R determines a person’s responsiveness to exercise.
Camille Bello, Communication and Membership Manager at Pharmabiotics Research Institute, underscores the conference’s regulatory focus and PRI’s role in guiding microbiome innovations through complex approval pathways.
Celine Druart, Executive Director at Pharmabiotic Research Institute, discusses the 10th Pharmabiotics Conference in Brussels, from microbiome biomarkers and One Health to key regulatory developments shaping live biotherapeutic products.
Veronica Ojetti, gastroenterologist at San Carlo di Nancy Hospital (Italy), presents findings from a single-center pilot study assessing the effects of L. reuteri LMG P-27481 on the gut microbiota and…
